EOSS Industries Holding GmbH
EOSS Management GmbH

A – 8010 Graz
Am Eisernen Tor 3
+43 316 269 205
office@eoss.at

7iD Technologies
www.7id.com

Bürocenter
www.eoss.at

EOSS Wireless
www.eoss.at

Innophore
www.innophore.com

Acceler8
www.acceler8.at

DevLabs
www.devlabs.ba

Fil Man Made Group
www.filmanmadegroup.com

Medovis Healthcare
www.medovis.at

ACL advanced commerce labs
www.acl.at

EOSS Immobilien
www.eoss.at

Genspeed Biotech
www.genspeed-biotech.com

nc digitalis
www.digitalis.at

PST Public Safety Technologies
www.pst.at

RANOREX
www.ranorex.com

Triestina Kurhotel
www.triestina.at

Wireless Montenegro http://www.wirelessmontenegro.com/

  

GENSPEED BIOTECH

Fast results to drive decisions – GENSPEED Biotech develops, produces and sells rapid diagnostic tests based on the patented GENSPEED® technology.

 
Diagnosis directly at the point of care enables rapid information – and thus immediate, knowledge-based treatment. The pioneers in this area are so-called strip tests (lateral flow immunochemistry assays, for example pregnancy tests) and miniaturised laboratory equipment (for example blood sugar meters). Strip tests are popular above all due to their low costs and simple handling, but they lose out substantially in terms of sensitivity and automation. With its patented GENSPEED® technology, Genspeed Biotech has combined the respective advantages of both technologies. The GENSPEED R2 combines rapid hybridisation through capillary and shear forces by means of optimal microfluidics, simple and highly-sensitive analysis by means of patented optical detection systems, and the application of reagents by means of an automated cartridge system. The GENSPEED technology enables RNA and proteins to be detected directly, while DNA can be detected indirectly (after undertaking a
polymerase chain reaction). GENSPEED is thus the perfect partner for manufacturers of LFIAs in order to enable multiplexing, increased sensitivity and quantifiability, and also for laboratory test manufacturers, in order to make tests cheaper and provide them at the point of care. As well as the platform, twelve years of development work have resulted in the market launch of an IVD-CE certified product range with test kits: Genspeed® HAI enables the rapid detection of all relevant hospital germs, and covers methicillin-resistant Staphylococcus aureus, Clostridium difficile, Carbapenem resistance and Vancomycin-resistant bacteria. PerioPOC® is a kit for dentists that enables a rapid differential diagnosis, treatment decision and treatment monitoring directly in the dental practice when treating periodontitis. GENSPEED is developing further test kits based on the GENSPEED® technology in close cooperation with a series of international partners.

 WEBSITE

 
 

MANAGEMENT

 



Sonja Kierstein
CTO
•••
+43 664 819 2993


Max Sonnleitner
CEO
•••
+43 664 819 2993


Christoph Blaschitz
CFO
•••
+43 316 269 205

LOCATION

CUSTOMERS